Literature DB >> 6752859

The cardiovascular system in cystic fibrosis.

A J Moss.   

Abstract

Available evidence indicates that cystic fibrosis causes widespread involvement of the cardiovascular system. Aside from the heart, unusual aberrations have been observed in the bronchial arteries, the aorta, and the systemic capillaries. Of all cardiovascular complications, cor pulmonale is the most serious. Recognition of a significant degree of cor pulmonale is generally possible on the basis of the severity of the underlying disease. Although echocardiography and radionuclide angiography are valuable research tools in the study of cor pulmonale in cystic fibrosis, they add little, from a practical standpoint, to the management of the patient. The basis of cor pulmonale is hypoxemia and unless this is relieved, no enduring effect can be expected from therapy directed toward the heart. Inasmuch as cystic fibrosis is a progressive disease, cor pulmonale is also progressive. At best, cardiac treatment represents a delaying action that may provide more time to combat an intercurrent infection.

Entities:  

Mesh:

Year:  1982        PMID: 6752859

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

Review 1.  The heart in cystic fibrosis.

Authors:  Rowland J Bright-Thomas; A Kevin Webb
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Cor pulmonale in cystic fibrosis.

Authors:  M H Götz; O C Burghuber; U Salzer-Muhar; W Wolosczuk; M Weissel; E Hartter
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

3.  Diuretic effect and disposition of furosemide in cystic fibrosis.

Authors:  J Prandota; I J Smith; B C Hilman; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

5.  Right ventricular performance and pulmonary haemodynamics in adolescent and adult patients with cystic fibrosis.

Authors:  O C Burghuber; U Salzer-Muhar; H Bergmann; M Götz
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

Review 6.  Pulmonary hypertension in children: perioperative management.

Authors:  F A Burrows; J R Klinck; M Rabinovitch; D J Bohn
Journal:  Can Anaesth Soc J       Date:  1986-09

7.  Portal venous blood flow in cystic fibrosis: assessment by Duplex Doppler sonography.

Authors:  K A Vergesslich; M Götz; G Mostbeck; G Sommer; W Ponhold
Journal:  Pediatr Radiol       Date:  1989

Review 8.  Pulmonary hypertension survival effects and treatment options in cystic fibrosis.

Authors:  Adriano R Tonelli
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

9.  Myocardial fibrosis--a rare complication in patients with cystic fibrosis.

Authors:  W Wiebicke; A Artlich; I Gerling
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

10.  Changes in nocturnal oximetry after treatment of exacerbations in cystic fibrosis.

Authors:  M B Allen; A F Mellon; E J Simmonds; R L Page; J M Littlewood
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.